Sponsors streamline insulin ranges

Nicholas O’Donoghue 23/12/2025

TGA confirms seven insulin products are set to be discontinued in 2026 Eli Lilly and Novo Nordisk plan to discontinue the supply of some of their insulin products in the second half of 2026, the Therapeutic Goods Administration (TGA) reports. The TGA noted that Eli Lilly has indicated that it will cease the supply of its Humalog vials (insulin lispro), Humulin

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Sponsors streamline insulin ranges

Previous ‘Implement them all’

Next 2025: a year for growth and change - part two

MENU

ajp.com.au

Previous ‘Implement them all’

Next 2025: a year for growth and change - part two

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.